Abbott Laboratories (NYSE:ABT) to go ex-dividend.On 12/15/2017 Abbott Laboratories ( NYSE:ABT ) announced that it will be issuing a quarterly dividend in the amount of $0.28 down from
- On 12/14/2012 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 2/15/2013 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 6/14/2013 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 9/12/2013 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 10/16/2013 Abbott Laboratories announced a quarterly dividend of $0.22.
- On 2/21/2014 Abbott Laboratories announced a quarterly dividend of $0.22.
Recent Insider Trading for Abbott Laboratories (NYSE:ABT)
- On 12/14/2017 Daniel Gesua Sive Salvadori, Insider, sold 28,319 with an average share price of $54.92 per share and the total transaction amounting to $1,555,279.48.
- On 12/6/2017 Miles D White, Chairman, sold 276,886 with an average share price of $54.41 per share and the total transaction amounting to $15,065,367.26.
- On 11/30/2017 Sharon J Bracken, Insider, sold 2,188 with an average share price of $56.12 per share and the total transaction amounting to $122,790.56.
- On 11/22/2017 Alejandro D Wellisch, Insider, sold 2,153 with an average share price of $55.86 per share and the total transaction amounting to $120,266.58.
- On 11/17/2017 Brian J Blaser, Insider, sold 23,866 with an average share price of $55.55 per share and the total transaction amounting to $1,325,756.30.
- On 11/14/2017 Daniel Gesua Sive Salvadori, Insider, sold 71,157 with an average share price of $55.00 per share and the total transaction amounting to $3,913,635.00.
Recent Analyst Rating for Abbott Laboratories (NYSE:ABT)
- On 12/12/2017 BMO Capital Markets, Upgrade, fromMarket Perform to Outperform to Market Perform with a price target of $58.00 to $65.00
- On 10/19/2017 Barclays, Reiterated Rating, to Overweight
- On 10/19/2017 Citigroup, Reiterated Rating, to Neutral
- On 10/19/2017 Cowen, Set Price Target, to bought with a price target of $55.00 to $68.00
- On 10/19/2017 Stifel Nicolaus, Boost Price Target, fromBuy to Buy to Buy with a price target of $58.00 to $63.00
- On 10/19/2017 Royal Bank of Canada, Boost Price Target, fromOutperform to Outperform to Outperform with a price target of $55.00 to $60.00
Recent Trading for Abbott Laboratories (NYSE:ABT) Shares of Abbott Laboratories closed the previous trading session at 55.50 up +0.78 1.43% with 54.84000015258789 shares trading hands.